Khan Muzammil, Rashid Mamoon Ur, Zafar Hammad, Ullah Waqas, Khan Abu H
Internal Medicine, Khyber Teaching Hospital, Peshawar, PAK.
Internal Medicine, AdventHealth, Orlando, USA.
Cureus. 2020 Feb 4;12(2):e6871. doi: 10.7759/cureus.6871.
Radiofrequency catheter ablation has been commonly used for the treatment of drug-refractory atrial fibrillation. The esophageal injury along with the development of atrial-esophageal fistula (AE fistula) is fairly rare but is a devastating complication of catheter ablation. Described in 2004 for the first time, it is the most lethal of all the complications of catheter ablation with a high mortality rate. The clinical presentation of an AE fistula is variable, however, early diagnosis and treatment can prevent a fatality. We have reported a case of an AE fistula post catheter ablation for drug-resistant atrial fibrillation, along with its treatment, diagnosis, and possible preventive measures.
射频导管消融术已普遍用于治疗药物难治性心房颤动。食管损伤以及心房食管瘘(AE瘘)的形成相当罕见,但却是导管消融术的一种毁灭性并发症。该并发症于2004年首次被描述,是所有导管消融术并发症中最致命的,死亡率很高。AE瘘的临床表现各不相同,然而,早期诊断和治疗可以避免死亡。我们报告了一例药物抵抗性心房颤动导管消融术后发生AE瘘的病例,以及其治疗、诊断和可能的预防措施。